Categories: Program and Feature News

|

Published: July 25, 2022

Renowned neurologist to lead enhanced research strategies on heart-brain health connection

American Heart Association names Mitchell Elkind for new leadership role to elevate clinical research activities related to stroke, brain health and other emerging science linked to cardio/cerebral vascular disease

Related Images

Mitchell S.V. Elkind M.D., M.S., FAAN, FAHA

Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.

News release

copyright American Heart Association 2022

Download (14.6 MB)

Mitchell S.V. Elkind M.D., M.S., FAAN, FAHA — Mitchell S.V. Elkind M.D., M.S., FAAN, FAHA

Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.

News release

copyright American Heart Association 2022

Download (14.6 MB)

American Heart Association logo

Heart and Torch with American Heart Association text.

https://www.heart.org/en

Usage agreement

copyright American Heart Association

Download (98.4 kB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED